DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

Gilead Sciences (NASDAQ: GILD)

107.78 -0.21 (-0.19%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $107.78 -0.19%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $106.96
Previous Close $107.99
Daily Range $106.78 - $108.79
52-Week Range $85.95 - $123.37
Market Cap $158.2B
P/E Ratio 11.36
Dividend (Yield) $1.72 (1.6%)
Ex-Dividend Date
Dividend Pay Date
09/14/15
09/29/15
Volume 10,749,103
Average Daily Volume 11,130,411
Current FY EPS $11.99

Sector

Healthcare

Industry

Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary Rss Feed

Bouncing Biotech? 3 Stocks To Buy

It may be time to consider buying Gilead Sciences, Celgene Corp, and Regeneron on sale.

The Stock Market Speaks - We Learn Irrationality Isn't Always Associated With 'Exuberance' And 'Euph

The Stock Market Speaks - We Learn Irrationality Isn't Always Associated With 'Exuberance' And 'Euphoria'

Pfizer (PFE) Gains on Label Expansion Efforts for Ibrance

Exelixis Up on Swiss Approval of Advanced Melanoma Drug

Benzinga's M&A Chatter for Thursday August 27, 2015

12 Attractive Fast-Growing Dividend Growth Stocks for High Total Return

12 Attractive Fast-Growing Dividend Growth Stocks For High Total Return

Biogen And Gilead Sciences Catch The Eye Of Short Sellers

What To Buy Now

J&J to Sell Sugar Substitute Splenda to Heartland Food

Novartis' (NVS) Promacta Label Further Expanded in U.S.

See More GILD News...

GILD's Top Competitors

GILD $107.78 (-0.19%)
Current stock: GILD
AMGN $155.89 (0.11%)
Current stock: AMGN
CELG $124.04 (0.81%)
Current stock: CELG
$0.00 (0.00%)
Current stock: